INOVIO PHARMACEUTICALS, INC. — Director's Dealing 2021

May 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INOVIO PHARMACEUTICALS, INC. (INO)
CIK: 0001055726
Period of Report: 2021-05-13

Reporting Person: Zoth Lota S. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-14	Common Stock	M	8700	—	Acquired	23932	Direct
2021-05-17	Common Stock	S	2045	$6.62	Disposed	21887	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-13	Common Stock Options	$6.23	A	27000	Acquired	2031-05-13	Common Stock (27000.0)	Direct
2021-05-13	Restricted Stock Unit	$	A	18000	Acquired		Common Stock (18000.0)	Direct
2021-05-14	Restricted Stock Unit	$	M	8700	Disposed		Common Stock (8700.0)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 14, 2021.

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3: This grant was made pursuant to the issuer's non-employee director compensation policy.

F4: Options to vest 100% on May 13, 2022.

F5: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 13, 2022.